Pattern of use and efficacy of daratumumab-based therapy in patients with relapsed/refractory light chain amyloidosis in a real-world setting: a single institution experience.

Dima, Danai; Hu, Xiao; Dower, Joshua; Zhang, Diana; Comenzo, Raymond; Varga, Cindy

Dima, Danai; Hu, Xiao; Dower, Joshua; Zhang, Diana; Comenzo, Raymond; Varga, Cindy.

Afiliação

Dima D; Hematology/Oncology Division, Cleveland Clinic Foundation, Cleveland, OH, USA.
Hu X; Hematology/Oncology Division, Tufts Medical Center, Boston, MA, USA.
Dower J; Hematology/Oncology Division, Tufts Medical Center, Boston, MA, USA.
Zhang D; Internal Medicine Division, Massachusetts General Hospital, Boston, MA, USA.
Comenzo R; The John C Davis Myeloma and Amyloid Program in the Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, USA.
Varga C; The John C Davis Myeloma and Amyloid Program in the Division of Hematology-Oncology, Tufts Medical Center, Boston, MA, USA.

Leuk Lymphoma ; 63(5): 1246-1250, 2022 05.

Article em En | MEDLINE | ID: mdl-34978254

Assuntos

Amiloidose; Amiloidose de Cadeia Leve de Imunoglobulina; Mieloma Múltiplo; Amiloidose/diagnóstico; Amiloidose/tratamento farmacológico; Anticorpos Monoclonais/uso terapêutico; Humanos; Amiloidose de Cadeia Leve de Imunoglobulina/diagnóstico; Amiloidose de Cadeia Leve de Imunoglobulina/tratamento farmacológico; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Amiloidose / Mieloma Múltiplo Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google